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A review of the literature shows that we owe the first
medical description of a child with Down syndrome to Jean-
E´tienne Dominique Esquirol in 1838. It would be 28 years
until John L. Down published a paper accurately describing
the characteristics of this syndrome, which is therefore
named after him.1 In 1959, Lejeune and Jacobs indepen-
dently determined that Down syndrome was linked to
trisomy 21.2 At the time of publication, Down syndrome is
the most common chromosomal abnormality, causing
intellectual disability with intelligence quotients (IQs) in
the range of 20–85.3 In general terms, there is no racial
predilection, the male to female ratio is approximately
1.1551, and it occurs in approximately 1 in 500 to 1 in 1000
live births.3,4 Furthermore, Down syndrome may present
considerable challenges, as manifestations may be quite
diverse and involve many organ systems, which may be
related to the cases of sudden death occurring in this
group.3 Moreover, we must point out that other diseases
underlying Down syndrome may be directly associated
with the fatal episodes observed in these individuals.
Epilepsy occupies an interesting role in this scenario. To
better understand this new paradigm, some hypotheses
must be put forward.
Epilepsy is one of the most common serious brain
disorders. Worldwide, epilepsy is estimated to affect 50
million people, most of whom live in developing countries
and therefore may have limited access to medical treat-
ment.5,6 Unfortunately, epilepsy is associated with a two- to
three-fold increase in mortality compared with the general
population, and sudden unexpected death is the most
important direct epilepsy-related cause of death.7 In general
terms, sudden unexpected death in epilepsy is responsible
for 7.5% to 17% of all deaths in epilepsy and has an
incidence among adults between 15500 and 151,000 patient-
years.8 The major risk factor for sudden unexpected death in
epilepsy is chronic, uncontrolled epilepsy9,10. In addition,
the major domain of potential mechanisms of sudden
unexpected death in epilepsy is autonomic, i.e., cardiac
abnormalities during and between seizures.9,11 Thus,
although progress continues to be made in the field of
sudden unexpected death in epilepsy in the last decade, the
dearth of published data about the relationship between
Down syndrome and sudden unexpected death in epilepsy
encouraged us to address some questions regarding this
specific topic.
As described previously, seizures in Down syndrome
could be considered an epiphenomenon, i.e., they could be a
consequence of the neurological alterations, both morpho-
logical and physiological, normally observed in this
population.12,13 Interestingly, the prevalence of epilepsy in
individuals with Down syndrome increases with age,
reaching almost 50% of all Down syndrome patients over
50 years of age.12 In general terms, approximately 8% of
individuals with Down syndrome have seizure disorders
that have been classified as partial seizures (47%), infantile
spasms (32%) or generalized tonic-clonic seizures (21%).12
Another interesting characteristic is the bimodal distribu-
tion of seizure onset: 40% of Down syndrome patients begin
having seizures before the age of 1 year, and 40% experience
seizures for the first time in the third decade of life.12 The
occurrence of primarily infantile spasms predominates in
the younger group, while partial seizures are more
frequently observed in the older Down syndrome group.
Tonic-clonic seizures seem to be equally distributed
throughout life12,14.
Taken together, these data raise the following question: Is
there a risk of sudden unexpected death in epilepsy in
individuals with Down syndrome who do not respond
optimally to the treatment established by neurologists to
control their seizures? Unfortunately, the answer is yes.
As previously mentioned, a number of associated factors
for sudden unexpected death in epilepsy have been reported,
but the results are not wholly consistent between studies. The
factors examined include refractoriness of the epileptic
condition, presence of generalized tonic-clonic seizures, early
onset of epilepsy, antiepileptic medication (polytherapy with
antiepileptic drugs), young age, and duration of the seizure
disorder.9,10 In addition, although the different mechanisms
may play separate roles in different cases, putative patho-
mechanisms include cardiac arrhythmia due to myocardial
ischemia, electrolyte disturbances, arrhythmogenic drugs or
transmission of epileptic activity via the autonomic nervous
system to the heart.11 In evaluating the data of these
conditions concurrently with data from Down syndrome
patients with seizure disorders, we can assume that these
individuals may be considered potential candidates for
sudden unexpected death in epilepsy. Moreover, we cannot
fail to mention that approximately 40% of individuals with
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Down syndrome have congenital cardiac anomalies,15,16
doubling the chance of having a fatal event and redoubling
our concern for these individuals. On the basis of this
probability, how might we proceed
We are unable to prevent the occurrence of these illnesses
or completely reverse the clinical picture when both have
already occurred. However, a few simple, common,
established strategies can be concurrently implemented by
neuroscientists. First, it should be asked whether the search
for some seizure-related event should be part of the clinical,
routine checks in Down syndrome patients. Second, if this
search is made, and considering that many individuals with
Down syndrome have congenital heart defects, it should be
asked whether palliative care of the cardiovascular system
of these patients should be redoubled. To accomplish this
redoubling, indispensable strategies, such as taking a
detailed cardiovascular history and screening for symptoms
of cardiovascular disease, cardiovascular risk factors and
prior cardiac findings (electrocardiogram and echocardio-
gram), should be conducted frequently. Third, physicians
who follow these patients should work collaboratively and
should suggest that these patients be treated in a transla-
tional manner, i.e., that treatments should integrate
advancements in basic science with clinical trials, taking
research from ‘‘bench-to-bedside.’’ 17 To do this effectively,
some important well-established translational strategies18
should be adopted, such as maintaining a healthy weight,
consuming a healthy and balanced diet, avoiding smoking,
limiting alcohol consumption, maintaining regular physical
activity (under the supervision of a qualified professional),
maintaining good quality sleep and improving stress
management by making time for relaxation and learning
healthier coping strategies. Additionally, establishing a diet
with omega-3 fatty acids from fish or fish oil supplements is
strongly recommended.
On the whole, we strongly believe it is time to establish a
taskforce to assess the state of knowledge regarding the
occurrence of sudden unexpected death in epilepsy in
Down syndrome, including clinical management, research
directions, and educational, social and cultural efforts. To
provide a better future for these patients, a list of the current
problems should be compiled and analyzed to determine
which feasibly-solved problems merit the most attention.
Finally, neuroscientists must be faithful to concepts origi-
nating in eastern cultures: Great achievements are possible
when you give importance to small beginnings.
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Figure 1 - The hypothesis that cardiovascular disturbances and
hence sudden unexpected death in epilepsy, at least in some
cases, could be related to the occurrence of refractory epilepsy in
people with Down syndrome is proposed. Furthermore, assum-
ing that 40% of individuals with Down syndrome have
cardiovascular abnormalities, this fact would further facilitate
the occurrence of a tragic eventin this specific population.
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